The metabolic changes that occur during the postnatal weaning period appear to be particularly important for future health, and human breast milk is considered to provide the optimal source of nutrition for infants. Our previous studies examined the effect of feeding type on antioxidative properties, glucose and insulin metabolism, the lipid profile, metabolomics, and prostaglandin (PG) metabolism in term and preterm infants. A urinary marker of oxidative DNA damage (8-hydroxy-2 0 -deoxyguanosine) was significantly lower in breast-fed term and preterm infants than in formula-fed infants. Markers of insulin sensitivity were significantly lower and atherosclerotic indices were significantly higher in breast-fed preterm infants than in mixed-fed infants at discharge. On urinary metabolomics analysis, choline, choline metabolites, and lactic acid were significantly lower in breast-fed term infants than in formula-fed infants. Urinary PGD 2 metabolite level in breast-fed term infants was also significantly lower than in formula-fed term infants. This indicates that human breast milk affects biological metabolism in early infancy.
The metabolic changes that occur in utero, during birth, and in the postnatal weaning period appear to be particularly important for future health. 1, 2 Human breast milk (BM) is considered the optimal source of nutrition for infants, and its importance in developmental or cognitive outcomes are recognized. [3] [4] [5] Furthermore, its benefit is greater in preterm infants compared with term infants. Although there are many genetic and environmental factors besides nutritional intake, information relating nutritional metabolism according to the type of feeding to future health is limited. The aim of this review is therefore to describe our research into the effect of BM on biological metabolism in early infancy.
Antioxidative properties of BM

Oxidative stress and antioxidants
Reactive oxygen species (ROS) is a collective term that includes not only oxygen free radicals (e.g. superoxide [O À 2 ] and hydroxyl radical [OH] ), but also non-radical derivatives of oxygen (e.g. hydrogen peroxide [H 2 O 2 ]). ROS are normally produced in living organisms and have the potential to react with almost every type of molecule in living cells. ROS are capable of damaging all biological macromolecules, including lipids, proteins, polysaccharides, and DNA. Oxidative stress (OS) can be defined as an imbalance between the amount of ROS and intra-and extracellular antioxidant protection systems. Antioxidants may be broadly classified into enzymatic (superoxide dismutase, catalase, glutathione peroxidase, and glutathione or their precursors) or non-enzymatic (Table 1) . 6 The transition from fetal to neonatal life at birth implies acute and complex physiological changes. The fetus transitions from an intrauterine hypoxic environment with partial pressure of oxygen (PO 2 ) 20-25 mmHg to an extrauterine normoxic environment with PO 2 100 mmHg. This four-five-fold increase is believed to induce increased production of ROS. Furthermore, many mechanisms lead to ROS overproduction in the perinatal period, including ischemia-reperfusion, the arachidonic acid cascade, free iron, the nitric oxide cascade, phagocyte activation, hypoxia, and hyperoxia. 7, 8 Indeed, OS may be involved in serious diseases in premature infants, including necrotizing enterocolitis (NEC), chronic lung disease, and retinopathy of prematurity (ROP). 9 
BM and antioxidative protection
The BM contains various antioxidative agents, including enzymes (catalase, glutathione peroxidase, and superoxide dismutase), constituents of antioxidative enzymes (e.g. Cu and Zn), vitamins (A, C, and E), and binding proteins (e.g. lactoferrin; Table 1) . 10 In contrast, infant formulas do not contain appreciable amounts of antioxidative enzymes, 11 but mean vitamin content generally tends to be higher than in BM to allow for reduced bioavailability. Therefore, the overall antioxidant capacity of BM versus infant formula is difficult to assess, although it probably favors BM. 12 Feeding with BM has been associated with a lower incidence of a variety of illnesses in premature infants, including NEC, 13 respiratory disease, 14 and ROP.
In a previous study, we compared OS in 41 healthy 1-month-old infants and 29 premature infants by measuring urinary 8-hydroxy-2 0 -deoxyguanosine (8-OHdG; a marker of oxidative DNA damage). 16 Urinary 8-OHdG excretion in breast-fed term infants was significantly lower than that in formula-fed term infants (Fig. 1) . In premature infants, urinary 8-OHdG excretion in breast-fed infants at 14 and 28 days of age was significantly lower than that in formulafed infants (Fig. 2) . 17 This indicates that BM provides more antioxidant properties than infant formula during early infancy. This may be due to the presence of antioxidants in BM, which may have antioxidant effects in the gut that pass through the relatively porous neonatal intestine early in infancy. 18, 19 Cell culture experiments
We previously reported in vitro results showing that BM alleviated H 2 O 2 -induced oxidative damage in an intestinal epithelial cell line, whereas bovine milk or infant formula did not. 20 Confluent rat intestinal epithelial cell line (IEC-6) was preincubated with defatted BM, bovine milk, or three infant formulas for 24 h, followed by an H 2 O 2 challenge. BM-treated cells had the highest survival rate (50%) compared with bovine milk-treated (6%), or infant formula-treated (13-16%) cells (Fig. 3) . 20 This showed that BM alleviated H 2 O 2 -induced oxidative damage in IEC-6 cells, whereas bovine milk and infant formula did not show any antioxidative capacity. This suggests that BM acts as an antioxidant in the gastrointestinal tract of infants. We also demonstrated antioxidative properties of iron-unsaturated human lactoferrin 21 and spermine, 20 which 300 * * * were assumed to be major antioxidants contained in BM, in cell culture experiments.
Effects of BM on metabolic syndrome
Clinical indices for metabolic syndrome
Breast-feeding is inversely associated with adult risk factors for metabolic syndrome (MetS), including hypertension, 22, 23 obesity, 24, 25 and insulin resistance. 26, 27 Many methods and indices are available for estimating insulin resistance. The gold standard methods for measuring insulin sensitivity and pancreatic b-cell function are the hyperinsulinemic-euglycemic clamp and hyperglycemic clamp, respectively. These procedures, however, are invasive and labor intensive. Some simple methods, from which indices can be derived, have been validated. These methods include the homeostasis model assessment of insulin resistance and quantitative insulin sensitivity check index (QUICKI = 1/[log insulin (lU/mL) + log glucose(mg/dL)]). Several lipoprotein ratios or atherogenic indices have been defined in an attempt to optimize the predictive capacity of the lipid profile. Based on total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and highdensity lipoprotein cholesterol (HDL-C), the TC/HDL-C and LDL-C/HDL-C ratios are recognized as risk indicators with a greater predictive value than isolated parameters used independently. 28 The major apoprotein present in HDL is apolipoprotein-A1 (apoA1), which provides structural stability to the spherical molecule. In LDL, apolipoprotein-B (apoB) constitutes most of the protein content. Therefore, the apoB/apoA1 ratio is important when determining atherogenic risk, and can be more useful than the TC/HDL-C and LDL-C/HDL-C ratios in adults. 28 Exposure to the atherogenic lipid profile contributes to atherosclerosis development, which may start in childhood. 29 Elevated LDL-C in children has been shown to predict an increase in the intima-media layer thickness of the arteries in adults. 30 Furthermore, the apoB/apoA1 ratio is associated with MetS components such as increased waist circumference and blood pressure, and low HDL-C in children. 31, 32 
Indices for MetS in preterm infants
In a previous study, we compared the indices of MetS in preterm infants (mean gestational age, 32.9 weeks) at the time of discharge (mean corrected age, 37.4 weeks). 33 Blood glucose and serum insulin were used to calculate QUICKI. We also measured serum TC, LDL-C, HDL-C, apoA1, and apoB, and TC/HDL-C, LDL-C/HDL-C, and apoB/apoA1. There were 22 infants in the BM group (received ≥ 90% of their intake from BM) and 19 in the mixed-feeding group (received ≥ 50% of their intake from formula). QUICKI was significantly higher in the BM group than in the mixed-feeding group (Fig. 4) . 33 TC, HDL-C, and apoA1 were not significantly different between the groups, but LDL-C and apoB were significantly higher in the BM group than in the mixed-feeding group (Fig. 5) . 33 The TC/HDL-C, LDL-C/HDL-C, and apoB/apoA1 ratios were significantly higher in the BM group than in the mixed-feeding group (Fig. 5) . 33 A modest inverse association was also seen between breast-feeding and circulating insulin in infancy. 34 BM contains hormones, such as leptin, adiponectin, resistin, and ghrelin, which play important roles in regulating energy balance and in glucose homeostasis. 35 Plasma TC, LDL-C, and apoB concentration, however, is increased in breast-fed term infants. 36, 37 The higher blood cholesterol in breast-fed term infants might be due to a higher intake of dietary cholesterol from BM. 38 Singhal et al. 39 reported that breast-feeding of preterm infants was associated with reduction in atherogenic indices such as LDL-C/HDL-C and apoB/ apoA1 at adolescence. This may be explained by a previously reported mechanism in which early cholesterol exposure was thought to suppress endogenous cholesterol synthesis by downregulating hepatic hydroxymethylglutaryl coenzyme A reductase. 40 In preterm infants, the type of feeding exposure in the early postnatal period may affect glucose, lipid, and apolipoprotein metabolism, and affect markers of MetS. 33 
Effects of BM on metabolomics
Metabolomics is a powerful tool in comprehensive measurement of low-molecular-weight metabolites in biological systems, and it has been extensively used in disease and plant studies. 41 Metabolomic analysis of urine is used to understand metabolic processes associated with nutrition. Metabolomic analysis is also used to identify biomarkers for diagnosis, prognosis, and risk prediction of different diseases during the neonatal period. 42, 43 Recently, we determined the effect of feeding type on 1-and 6-month-old healthy term infants using urinary metabolome analysis with capillary electrophoresis-time-of-flight mass spectrometry (CE-TOF/ MS). 44 Urine samples were collected from 19 and from 14 infants at 1 and 6 months, respectively. Infants were separated into two groups as follows: the breast-fed group (n = 13 at 1 month; n = 9 at 6 months) and the formula-fed group (n = 6 at 1 month; n = 5 at 6 months). A total of 29 metabolites were detected on CE-TOF/MS metabolome analysis in all samples (Table 2 ). Urinary excretion of and (□) mixed-feeding (n = 19) preterm infants at discharge from the neonatal intensive care unit (mean AE SD). *P < 0.05; **P < 0.01.
choline metabolites (choline, N,N-dimethylglycine, sarcosine, and betaine) at 1 month was significantly higher in breastfed infants than in formula-fed infants (P < 0.05). Choline metabolites, however, were not significantly different between the groups at 6 months (Fig. 6 ). Urinary excretion of lactic acid in breast-fed infants at 1 and 6 months was significantly lower than in formula-fed infants (Fig. 7) . Urinary L(À)-threonine and L-carnosine excretion at 1 month was significantly lower in breast-fed infants than in formula-fed infants, but it was not significantly different between the groups at 6 months (Fig. 7) . On principal component analysis, most plots for the breast-fed group were separate from those for the formula-fed group at 1 month, in which component 1 accounted for 38.6% and component 2 accounted for 27.3% of the total variance (Fig. 8) . To further assess individual differences between the urine samples, they were also compared and visualized as a heat map image (Fig. 9) . We found that the type of feeding in early infancy affected choline metabolism, as well as lactate, threonine, and carnosine levels, in healthy term infants. 44 The choline content of formula milk available in Japan is approximately 12 mg/100 kcal. The mean choline content in Japanese mothers' BM is approximately 13.6 mg/100 kcal. 45 The difference in the absorption ratio of choline between Fig. 9 Hierarchical clustering heatmap of biologically relevant metabolites in urine sample of term infants at 1 and 6 months of age. Heat map show global metabolic changes for each variable: red, increase; blue, decrease; yellow, no relative change. A warm color (e.g. red) represents a higher metabolite content than does a cold color (e.g. blue).
BM and formula may affect urinary choline and choline metabolite levels at 1 month. Enhanced post-prandial insulin concentration in formula-fed infants has been reported to increase the circulating level of lactate following an increase in cellular glucose uptake. 46 Urinary metabolome analysis using CE-TOF/MS is useful for assessing nutritional metabolism in infants.
Effects of BM on prostaglandin metabolites
Metabolism of PG
Fat is a critical component of BM, and provides energy and nutrients required for development of the central nervous system. 47 Long-chain polyunsaturated fatty acids (LC-PUFA), including docosahexaenoic acid (22:6n-3) and arachidonic acid (AA) 20:4n-6, are always present in BM. Although synthesis of DHA and AA is limited in infants, these fatty acids play major roles in the structure and function of human tissues, immune function, and brain and retinal development during gestation and infancy. 48 Formation of AA in the phospholipid cell membrane is followed by its metabolism by cyclo-oxygenases and lipoxygenases. This leads to production of eicosanoids, such as prostaglandins (PG), thromboxane A 2 , leukotrienes, and hydroxyeicosatetraenoic acid. Prostanoids, such as PGE 2 and PGD 2 , are produced by a variety of structural and inflammatory cells. 49 Direct measurement of PGE 2 and PGD 2 in biological fluids is often difficult because of their chemical instability. Therefore, the most accurate index of endogenous prostanoid production in humans is thought to be measurement of excreted urinary metabolites. The final urinary metabolite of PGE 2 , 9,15-dioxo-11a-hydroxy-13,14-dihydro-2,3,4,5-tetranor-prostan-1,20-dioic acid (tetranor PGEM; t-PGEM), is considered to best reflect the systemic level of PGE 2 formation. 50 In vivo and in vitro, PGD 2 is rapidly degraded into D-, F-, and J-ring metabolites, which are excreted as more stable urinary metabolites. 51 The D-ring metabolite 11, that is, 15-dioxo-9a-hydrox-2,3,4,5-tetranor-prostan-1,20-dioic acid (tetranor PGD 2 metabolite; t-PGDM) is more abundant than F-ring metabolites. 51, 52 The metabolites t-PGEM and t-PGDM are present in urine, and accurately reflect the biosynthesis of PGE 2 and PGD 2 , respectively (Fig. 10) . 51, 53 Urinary PG metabolites
Recently, we conducted a study to determine the effect of feeding type on urinary t-PGEM and t-PGDM in healthy term infants at 1 and 6 months using liquid chromatography tandem mass spectrometry (LC-MS/MS). Urine samples were collected from 19 infants at 1 month of age. A total of 13 infants were in the breast-fed group and the other six were exclusively fed on formula. At 6 months, we sampled 14 infants, including nine who were breast-fed and five who received formula. Urinary t-PGDM excretion at 1 and 6 months was significantly lower in breast-fed infants than in formula-fed infants (Fig. 11a) . Urinary t-PGEM excretion at 1 and 6 months, however, was not significantly different between the groups (Fig. 11b) . Urinary t-PGDM is a potentially useful biomarker of in vivo activity of mast cells. 54 Furthermore, intestinal mucosal mast cells are critically involved in the development of food-induced allergic disorders. 55 A difference in LC-PUFA content between BM and formula might affect intestinal mucosal mast cells during infancy. The type of feeding in early infancy was therefore shown to affect PG metabolism in healthy term infants. 56 In conclusion, as per the summary of the clinical studies in Table 3 , BM affects OS, insulin sensitivity and lipid profile, choline, and PG metabolism in term and preterm infants during early infancy. Analysis of urine samples is useful for assessing nutritional metabolism in infants. Further research is needed to modify the content of artificial formulas and to improve the future health of formula-fed infants. Urinary 8-OHdG excretion of BF infants was significantly lower than that of FF and MF infants at 1 month of age. 16 Insulin sensitivity QUICKI index was significantly higher in BF infants than in MF infants at 37.4 weeks of corrected age.
33
Lipid metabolism LDL-C and apoB were significantly higher in BF infants than in MF infants. TC/HDL-C, LDL-C/HDL-C, and apoB/apoA1 ratios were significantly higher in BF infants than in MF infants.
Metabolome analysis -Urinary excretion of choline metabolites was significantly higher in BF infants than in FF infants at 1 month of age. Urinary excretion of lactic acid in BF was significantly lower than that in FF infants at 1 and 6 months of age. 44 PG metabolism -Urinary t-PGDM excretion was significantly lower in BF infants than in FF infants at 1 and 6 months of age. 56 8-OHdG, 8-hydroxy-2 0 -deoxyguanosine; apo, apolipoprotein; BF, breast-fed; FF, formula-fed; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MF, mixed-feeding; PG, prostaglandin; QUICKI, quantitative insulin sensitivity check index; TC, total cholesterol; t-PGDM, tetranor prostaglandin D 2 metabolite (15-dioxo-9a-hydrox-2,3,4,5-tetranor-prostan-1,20-dioic acid). tetranor-PGEM (tetranor-prostaglandin E 2 metabolite; 9,15-dioxo-11a-hydroxy-13,14-dihydro-2,3,4,5-tetranor-prostan-1,20-dioic acid) excretion in term infants at 1 and 6 months of age. (a) **P < 0.01, formula group vs the breast milk group; (b) *P < 0.05, 1 month vs 6 months in the formula group.
